B Gilson

Infective Endocarditis

EULAR recommendations for the management of primary small and medium vessel vasculitis

A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

Small-Vessel Vasculitis

Rapid decrease of anti-β-glucan antibody as an indicator for early diagnosis of carinii pneumonitis and deep mycotic infections following immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis

A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized wegener's granulomatosis

Updated Clinical Classification of Pulmonary Hypertension

Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century

The biology and function of fibroblasts in cancer

Wegener's granulomatosis: clinical course in 108 patients with renal involvement

TFOS DEWS II pathophysiology report

An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients

Gonococcal Endocarditis: Twenty-Five Year Experience

Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: Results of a multicenter, prospective, open‐label study of twenty‐two patients

Updated Clinical Classification of Pulmonary Hypertension

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

Ocular Sarcoidosis

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Chances of Renal Recovery for Dialysis-Dependent ANCA-Associated Glomerulonephritis

Polyarteritis nodosa: A contemporary overview

Long-term patient survival in ANCA-associated vasculitis

Immunosuppressive therapy in lupus‐ and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty‐three cases

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

An approach to the diagnosis and management of systemic vasculitis

Interventions for renal vasculitis in adults

Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis

POLYARTERITIS NODOSA, MICROSCOPIC POLYANGIITIS, AND CHURG-STRAUSS SYNDROME

Endocarditis Due to Rare and Fastidious Bacteria

Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical aspects and treatment.

Infective endocarditis—1973

Sarcoïdose pneumo-rénale apparue sous anti-TNFα

Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: A prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty‐five patients

Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis.

Gonococcic endocarditis.

[Extracapillary and necrotizing glomerulonephritis without immunoglobulin deposits: clinical presentation, prognostic factors and response to treatment. Apropos of 42 cases].